The CEO of VanEck, Jan van Eck, has recognized a significant sentiment shift in the cryptocurrency market following the U.S. Securities and Exchange Commission’s approval of a rule change allowing for Ethereum exchange-traded funds. Describing it as one of the most remarkable developments in securities regulation in his career, van Eck emphasized the importance of
0 Comments
Pfizer’s drug for an advanced form of lung cancer, Lorbrena, has shown promising long-term results in a late-stage trial. The drug has helped patients live longer without cancer progression, with most patients experiencing this benefit for over five years. Additionally, Lorbrena has been found to reduce the risk of cancer progression in the brain, a
0 Comments
For individuals who fall into the category of higher earners and are seeking ways to maximize tax-free retirement savings, there is a potential strategy that often goes unnoticed. While Roth individual retirement accounts are known for their tax-free growth and other advantages, there are income limits that prevent some investors from making direct contributions. However,
0 Comments